Herpesviral Latency-Common Themes
- PMID:32075270
- PMCID: PMC7167855
- DOI: 10.3390/pathogens9020125
Herpesviral Latency-Common Themes
Abstract
Latency establishment is the hallmark feature of herpesviruses, a group of viruses, of which nine are known to infect humans. They have co-evolved alongside their hosts, and mastered manipulation of cellular pathways and tweaking various processes to their advantage. As a result, they are very well adapted to persistence. The members of the three subfamilies belonging to the family Herpesviridae differ with regard to cell tropism, target cells for the latent reservoir, and characteristics of the infection. The mechanisms governing the latent state also seem quite different. Our knowledge about latency is most complete for the gammaherpesviruses due to previously missing adequate latency models for the alpha and beta-herpesviruses. Nevertheless, with advances in cell biology and the availability of appropriate cell-culture and animal models, the common features of the latency in the different subfamilies began to emerge. Three criteria have been set forth to define latency and differentiate it from persistent or abortive infection: 1) persistence of the viral genome, 2) limited viral gene expression with no viral particle production, and 3) the ability to reactivate to a lytic cycle. This review discusses these criteria for each of the subfamilies and highlights the common strategies adopted by herpesviruses to establish latency.
Keywords: Alphaherpesvirinae; Betaherpesvirinae; Gammaherpesvirinae; gene expression; herpesvirus; latency; lytic cycle; lytic inducers; persistence; reactivation.
Conflict of interest statement
The authors declare no conflict of interest.
Figures

Similar articles
- Tegument protein control of latent herpesvirus establishment and animation.Penkert RR, Kalejta RF.Penkert RR, et al.Herpesviridae. 2011 Feb 8;2(1):3. doi: 10.1186/2042-4280-2-3.Herpesviridae. 2011.PMID:21429246Free PMC article.
- Pathogenesis of ruminant herpesvirus infections.Engels M, Ackermann M.Engels M, et al.Vet Microbiol. 1996 Nov;53(1-2):3-15. doi: 10.1016/s0378-1135(96)01230-8.Vet Microbiol. 1996.PMID:9010994Review.
- Role of Epitranscriptomic and Epigenetic Modifications during the Lytic and Latent Phases of Herpesvirus Infections.Soto AA, Ortiz G, Contreras S, Soto-Rifo R, González PA.Soto AA, et al.Microorganisms. 2022 Aug 30;10(9):1754. doi: 10.3390/microorganisms10091754.Microorganisms. 2022.PMID:36144356Free PMC article.Review.
- Rta of murine gammaherpesvirus 68 reactivates the complete lytic cycle from latency.Wu TT, Usherwood EJ, Stewart JP, Nash AA, Sun R.Wu TT, et al.J Virol. 2000 Apr;74(8):3659-67. doi: 10.1128/jvi.74.8.3659-3667.2000.J Virol. 2000.PMID:10729142Free PMC article.
- Lytic Replication and Reactivation from B Cells Is Not Required for Establishing or Maintaining Gammaherpesvirus LatencyIn Vivo.Gupta A, Owens SM, Oldenburg DG, White DW, Forrest JC.Gupta A, et al.J Virol. 2022 Jun 22;96(12):e0069022. doi: 10.1128/jvi.00690-22. Epub 2022 Jun 1.J Virol. 2022.PMID:35647668Free PMC article.
Cited by
- The Quest for Immunity: Exploring Human Herpesviruses as Vaccine Vectors.Kamel MS, Munds RA, Verma MS.Kamel MS, et al.Int J Mol Sci. 2023 Nov 9;24(22):16112. doi: 10.3390/ijms242216112.Int J Mol Sci. 2023.PMID:38003300Free PMC article.Review.
- Kaposi's sarcoma herpesvirus exploits the DNA damage response to circularize its genome.Li S, Liu B, Tan M, Juillard F, Szymula A, Álvarez ÁL, Van Sciver N, George A, Ramachandran A, Raina K, Tumuluri VS, Costa CN, Simas JP, Kaye KM.Li S, et al.Nucleic Acids Res. 2024 Feb 28;52(4):1814-1829. doi: 10.1093/nar/gkad1224.Nucleic Acids Res. 2024.PMID:38180827Free PMC article.
- The sulphated polysaccharides extract ulvans from Ulva armoricana limits Marek's disease virus dissemination in vitro and promotes viral reactivation in lymphoid cells.Bussy F, Rémy S, Le Goff M, Collén PN, Trapp-Fragnet L.Bussy F, et al.BMC Vet Res. 2022 Apr 27;18(1):155. doi: 10.1186/s12917-022-03247-y.BMC Vet Res. 2022.PMID:35477401Free PMC article.
- An Absence of Epstein-Barr Virus Reactivation and Associations with Disease Activity in People with Multiple Sclerosis Undergoing Therapeutic Hookworm Vaccination.Maple PAC, Gran B, Tanasescu R, Pritchard DI, Constantinescu CS.Maple PAC, et al.Vaccines (Basel). 2020 Aug 28;8(3):487. doi: 10.3390/vaccines8030487.Vaccines (Basel). 2020.PMID:32872342Free PMC article.
- Multiple Sclerosis, Viruses, and New Vaccines.Maple PAC.Maple PAC.Neurol Int. 2021 Dec 13;13(4):712-714. doi: 10.3390/neurolint13040068.Neurol Int. 2021.PMID:34940754Free PMC article.
References
- Pellett P.E., Roizman B. Herpesviridae. In: Knipe D.M., Howley P.M., editors. Fields Virology. 6th ed. Volume 2 Lippincott Williams & Wilkins; Philadelphia, PA, USA: 2013.
- Roizman B., Knipe D.M., Whitley R.J. Herpes Simplex Viruses. In: Knipe D.M., Howley P.M., editors. Fields Virology. 6th ed. Volume 2 Lippincott Williams & Wilkins; Philadelphia, PA, USA: 2013.
- Whitley R.J. Herpesviruses. In: Baron S., editor. Medical Microbiology. 4th ed. University of Texas Medical Branch at Galveston; Galveston, TX, USA: 1996.
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials